Huazhong Pharmaceutical Co., Ltd. (HPC), founded in 1995, with nearly three decades of expertise in pharmaceuticals , HPC is a leading manufacturer, exporter, and distributor of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) in China，with a strong reputation for delivering high-quality, cost-effective, and reliable solutions to partners worldwide. Our diverse portfolio covers innovative medicines for human use, veterinary and pet health products, as well as vitamin derivatives, making HPC a preferred partner for formulation companies across the globe.

In 2018, HPC expanded internationally with the establishment of Huazhong Pharmaceutical Japan in Tokyo. This strategic presence enables us to connect Japanese clients with China’s most competitive innovative drugs and essential raw materials. At the same time, our Tokyo office has introduced a wide range of finished formulations and health supplements from Honso Pharmaceutical Co., Ltd., a century-old Japanese pharmaceutical company, to the Chinese market, including OEM/contract customization (private-label) collaborations. The “Honso Overseas Flagship Store” has become a highlight at the China International Import Expo (CIIE) and a model for cross-border e-commerce in healthcare.

Since 1995, HPC Shanghai has been at the heart of our global services, supporting international FDF users with API sourcing in China. Our work focuses on vendor qualification and regulatory due diligence, logistics and distribution, as well as contracted annual inventory assurance under master purchasing agreements. Subject to credit underwriting, qualified end-users and manufacturers may obtain limited payment terms to foster stable, long-term procurement.

Today, HPC stands as a service provider, an innovator, and a bridge between global healthcare markets.

HPC — Creating Value, Delivering Trust.
HPC — Your Choice for a Global Partner.

華中藥業有限公司（HPC）创立于1995年，是中国领先的API原料药和制剂产品的生产商、出口商、分销商。产品类别包括了人用创新药和兽用宠物药及Vitamins系列衍生物的研发生产。为全世界的制剂生产制造商提供了物美价廉的产品，是中国著名品牌的创建者和专利技术持有人。

2018年華中藥業株式会社在日本東京成立，为日本用户提供中国市场最具竞争力的创新药产品和最基础的原材料供应链。同时，東京公司为中国市场提供了日本百年企业“本草製藥株式会社”生产的各类人用药制剂产品和保健食品包括提供了OEM合同订制等项目合作。“本草制药海外旗舰店”项目已成为中国进口博览会和跨境电商等服务贸易的明星企业。

華中藥業上海公司，自1995起，一直坚持为全球FDF用户提供在华API原料药采购服务、物流配送服务、合同内年单库存保障服务等。凡是最终产品的使用者和生产商，在资信担保下都可以获得有限的付款账期申请，以建立长期稳定的在华采购服务贸易。

華中藥業，生产商、服务商、进出口商。
華中藥業，您的选择。